Literature DB >> 17562137

Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy.

Sheng Liang1, Yongxian Wang, Junfeng Yu, Chunfu Zhang, Jiaoyun Xia, Duanzhi Yin.   

Abstract

Amino-functionalized superparamagnetic iron oxide nanoparticles (SPION) were synthesized by coprecipitation method. The particles were characterized by X-ray diffraction (XRD), vibrating sample magnetometer (VSM), scanning electron micrographs (SEM), transmission electron micrographs (TEM) and atomic force micrographs (AFM). The size of the modified particles varied in the range 10-15 nm and did not change significantly after modification. Hepama-1, an excellent humanized monoclonal antibody directed against liver cancer, was conjugated to the SPION to prepare immuno-magnetic nanoparticles (IMN). A direct labeling method was employed to radiolabel IMN with rhenium-188. The radiolabeling efficiency was about 90% with good in vitro stability. (188)Re labeled IMN could markedly kill SMMC-7721 liver cancer cells. Such SPION might be very useful for bio-magnetically targeted radiotherapy in liver cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562137     DOI: 10.1007/s10856-007-3130-6

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  10 in total

1.  Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation.

Authors:  U O Häfeli; W K Roberts; G J Pauer; S K Kraeft; R M Macklis
Journal:  Appl Radiat Isot       Date:  2001-06       Impact factor: 1.513

2.  Functional magnetic stimulation facilitates colonic transit in rats.

Authors:  V W Lin; I Hsiao; D Goodwin; I Perkash
Journal:  Arch Phys Med Rehabil       Date:  2001-07       Impact factor: 3.966

3.  Crystal size and properties of superparamagnetic iron oxide (SPIO) particles.

Authors:  C E Sjögren; C Johansson; A Naevestad; P C Sontum; K Briley-Saebø; A K Fahlvik
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

Review 4.  Magnetic microspheres: a vehicle for selective targeting of drugs.

Authors:  K J Widder; A E Senyei
Journal:  Pharmacol Ther       Date:  1983       Impact factor: 12.310

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer.

Authors:  Junfeng Yu; Urs O Häfeli; Mark Sands; Yonghua Dong
Journal:  Appl Radiat Isot       Date:  2003-05       Impact factor: 1.513

7.  Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.

Authors:  K J Widder; R M Morris; G A Poore; D P Howard; A E Senyei
Journal:  Eur J Cancer Clin Oncol       Date:  1983-01

8.  Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.

Authors:  K J Widder; P A Marino; R M Morris; D P Howard; G A Poore; A E Senyei
Journal:  Eur J Cancer Clin Oncol       Date:  1983-01

9.  Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.

Authors:  U O Häfeli; S M Sweeney; B A Beresford; J L Humm; R M Macklis
Journal:  Nucl Med Biol       Date:  1995-02       Impact factor: 2.408

10.  Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies.

Authors:  G L Griffiths; D M Goldenberg; F F Knapp; A P Callahan; C H Chang; H J Hansen
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

  10 in total
  9 in total

1.  A simple and highly sensitive method for magnetic nanoparticle quantitation using 1H-NMR spectroscopy.

Authors:  Jonathan Gunn; Rajan K Paranji; Miqin Zhang
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

Review 2.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

Review 3.  Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging.

Authors:  Omid Veiseh; Jonathan W Gunn; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

Review 4.  Nanotechnology, nanotoxicology, and neuroscience.

Authors:  Won Hyuk Suh; Kenneth S Suslick; Galen D Stucky; Yoo-Hun Suh
Journal:  Prog Neurobiol       Date:  2008-09-24       Impact factor: 11.685

5.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles.

Authors:  Hao Hong; Yin Zhang; Jiangtao Sun; Weibo Cai
Journal:  Nano Today       Date:  2009-10-01       Impact factor: 20.722

Review 6.  Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking.

Authors:  João Conniot; Joana M Silva; Joana G Fernandes; Liana C Silva; Rogério Gaspar; Steve Brocchini; Helena F Florindo; Teresa S Barata
Journal:  Front Chem       Date:  2014-11-26       Impact factor: 5.221

7.  Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.

Authors:  Liang-Ting Lin; Chun-Yuan Chang; Chih-Hsien Chang; Hsin-Ell Wang; Shih-Hwa Chiou; Ren-Shyan Liu; Te-Wei Lee; Yi-Jang Lee
Journal:  Oncotarget       Date:  2016-10-04

Review 8.  Recent Advancements of Magnetic Nanomaterials in Cancer Therapy.

Authors:  Sudip Mukherjee; Lily Liang; Omid Veiseh
Journal:  Pharmaceutics       Date:  2020-02-11       Impact factor: 6.321

Review 9.  Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics.

Authors:  Marcus Mkhatshwa; Joshua Mamolatelo Moremi; Katlego Makgopa; Amanda-Lee Ezra Manicum
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.